Merck snags Chinese obesity drug in nearly $2 billion deal
Merck will gain the exclusive global license for Chinese drugmaker Hansoh’s HS-10535, an experimental oral drug that targets GLP-1 receptors. Read More Bishhnu BanerjiHey, I am a multifaceted professional excelling in the realms of blogging, YouTube content creation, and entrepreneurship. With a passion for sharing knowledge and inspiring others, I established a strong presence in … Read more